University of Washington Department of Medicine, Division of Medical Genetics, and Institute for Stem Cell and Regenerative Medicine, Seattle, WA 98109, USA.
Hum Gene Ther. 2011 Jun;22(6):761-74. doi: 10.1089/hum.2010.233. Epub 2011 Mar 25.
The therapeutic application of recombinant retroviruses and other integrating gene transfer vectors has been limited by problems of vector expression and vector-mediated genotoxicity. These problems arise in large part from the interactions between vector sequences and the genomic environment surrounding sites of integration. Strides have been made in overcoming both of these problems through the modification of deleterious vector sequences, the inclusion of better enhancers and promoters, and the use of alternative virus systems. However, these modifications often add other restrictions on vector design, which in turn can further limit therapeutic applications. As an alternative, several groups have been investigating a class of DNA regulatory elements known as chromatin insulators. These elements provide a means of blocking the interaction between an integrating vector and the target cell genome in a manner that is independent of the vector transgene, regulatory elements, or virus of origin. This review outlines the background, rationale, and evidence for using chromatin insulators to improve the expression and safety of gene transfer vectors. Also reviewed are topological factors that constrain the use of insulators in integrating gene transfer vectors, alternative sources of insulators, and the role of chromatin insulators as one of several components for optimal vector design.
逆转录病毒和其他整合型基因转移载体的治疗应用受到载体表达和载体介导的遗传毒性问题的限制。这些问题主要源于载体序列与整合部位周围基因组环境之间的相互作用。通过修饰有害的载体序列、包含更好的增强子和启动子以及使用替代病毒系统,在克服这两个问题方面已经取得了进展。然而,这些修饰通常会对载体设计增加其他限制,这反过来又会进一步限制治疗应用。作为替代方案,有几个研究小组一直在研究一类称为染色质绝缘子的 DNA 调控元件。这些元件提供了一种在不依赖于载体转基因、调控元件或病毒来源的情况下,阻止整合载体与靶细胞基因组相互作用的方法。本综述概述了使用染色质绝缘子来提高基因转移载体表达和安全性的背景、原理和证据。还回顾了拓扑因素对绝缘子在整合基因转移载体中应用的限制、绝缘子的替代来源,以及作为最佳载体设计的几个组成部分之一的染色质绝缘子的作用。